Ignite Creation Date:
2025-12-24 @ 6:55 PM
Ignite Modification Date:
2025-12-29 @ 6:14 PM
Study NCT ID:
NCT03520257
Status:
UNKNOWN
Last Update Posted:
2018-05-09
First Post:
2018-04-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus
Sponsor:
Guangxi Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2018-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2018-04-17
First Submit QC Date:
None
Study First Post Date:
2018-05-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-08
Last Update Post Date:
2018-05-09
Last Update Post Date Type:
ACTUAL